Cypherpunk Technologies (CYPH) vs Prelude Therapeutics (PRLD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Cypherpunk Technologies (CYPH) has outperformed Prelude Therapeutics (PRLD) over the past year, gaining 387.2% versus a gain of 166.0%. Over five years, PRLD leads with a -76.4% price change compared with -90.3% for CYPH. Cypherpunk Technologies is the larger company by market cap ($328.7 million vs $305.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CYPH | PRLD |
|---|---|---|
| Share price | $3.05 | $3.83 |
| Market cap | $328.68M | $305.65M |
| 1-day change | -6.44% | +0.52% |
| YTD return | +162.93% | +32.07% |
| 1-year return | +387.22% | +165.97% |
| 5-year return | -90.32% | -76.45% |
| P/E ratio (TTM) | 4.84 | — |
| EPS (TTM) | $0.63 | $-0.73 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.19 | $6.83 |
| 52-week low | $0.393 | $1.15 |
| Distance from 52-week high | -27.21% | -43.92% |
| Average volume | 9.78M | 474.76K |
| Shares outstanding | 107.76M | 65.08M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CYPH has outperformed PRLD by 221.2 percentage points over the past year.
CYPH vs PRLD FAQ
Which is bigger, Cypherpunk Technologies or Prelude Therapeutics?
Cypherpunk Technologies (CYPH) is larger, with a market capitalization of $328.68M compared with $305.65M for Prelude Therapeutics (PRLD).
Which stock has performed better over the past year, CYPH or PRLD?
CYPH returned +387.22% over the past 12 months, compared with +165.97% for PRLD (price return, excluding dividends). Past performance does not predict future results.
Are Cypherpunk Technologies and Prelude Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.